How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Billionaire investor Ray Dalio said the booming artificial-intelligence market shows signs of a bubble that will eventually burst. “All great technology changes produce bubbles,” Dalio, the founder of ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Located in Pasadena, Calif., this futuristic dome — and affordable housing prototype — still stuns. Located in Pasadena, Calif., this futuristic dome — and affordable housing prototype — still stuns.

Forbes contributors publish independent expert analyses and insights. James Broughel is an economist focused on the economics of regulation. This voice experience is generated by AI. Learn more. This ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Just 20 of the S&P 500 members joined the index at a record close on Friday. Bank of America points out just 20 stocks hit new highs at the very top of the internet bubble in March 2000. The firm's ...

A merge sort uses smaller, ordered lists which are easier to sort and merge than larger lists. It is usually more efficient and quicker than the bubble sort. It is more complex to code. It will still ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...